Health ❯ Healthcare ❯ Patient Care ❯ Treatment Efficacy

Side Effects

Phase 1 TCER IMA401 Shows Early Safety and Tumor Responses in Solid Cancers

Data presented May 31 show manageable immune‑activation side effects and encouraging responses that justify planned combination studies and larger trials.

4 ARTICLES

2mo ago

Apnimed Pill Cuts Sleep Apnea Events in Phase 3 as Company Seeks FDA Approval

8 ARTICLES

8mo ago

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

8 ARTICLES

last yr.

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma